Skip to content

Clinical trials

Phase 1 Myositis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myositis Phase: Phase 1 Country / region: China Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20232
20245
202517
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18
Not yet recruiting6
Withdrawn3
Suspended2
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China Immunotech (Beijing) Biotechnology Co., Ltd.5
Nanjing Bioheng Biotech Co., Ltd.3
Tongji Hospital3
Nanjing Legend Biotech Co.2
RenJi Hospital2
AstraZeneca1
Beijing Boren Hospital1
Beijing GoBroad Hospital1
Changzhou No.2 People's Hospital1
Children's Hospital of Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myositis33
Lupus Erythematosus, Systemic26
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis19
Scleroderma, Systemic19
Sjogren's Syndrome11
Autoimmune Diseases8
Antiphospholipid Syndrome7
Arthritis, Rheumatoid5
Recurrence4
Anemia, Hemolytic, Autoimmune3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.